Skip to main content

COVID-19

audience learn
My favorite three presentations from day 4 at ACR 2021 included the following: Breakthrough Infections in Rheumatic Disease Patients Late-Breaking Abstract L16 - Dr. Jazvinder Singh presented the…
RT @ELittlejohnDO: Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheuma

Emily Littlejohn ELittlejohnDO

1 year ago
Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheumatic Diseases. A wonderful resource in talking to our patients about vaccine necessity! @CleClinicMD https://t.co/EA5jVYweHm
RT @Doctorkuch: #ACR21 Late breaking
#ACRambassador
Breakthrough COVID-19 Infections Post-vaccination Among Immunocompr

Marie Kuchynski MD Doctorkuch

1 year ago
#ACR21 Late breaking #ACRambassador Breakthrough COVID-19 Infections Post-vaccination Among Immunocompromised Patients with Autoimmune or Inflammatory Rheumatic Diseases: A Retrospective Cohort Analysis from a U.S. Nationally-sampled EMR Data Repository https://t.co/oyovR27Upm
RT @swethaann23: Reasons for COVID-19 vaccine hesitancy in rheumatology pts in southeast US based on survey study:

🔰

swethaann23 swethaann23

1 year ago
Reasons for COVID-19 vaccine hesitancy in rheumatology pts in southeast US based on survey study: 🔰Vaccine being “rushed” or “experimental” 🔰Safety of vaccine in the patients’ rheumatologic diagnoses 🔰Side effects 🔰Concern for Allergic reaction Abst#1589 #ACR21 @RheumNow https://t.co/xm15KxdA56
Factors Associated with Poor Vaccine Response in Rituximab: Dr. Yuzaiful Yusof (@Yuz6Yusof) discusses abstract #0437 pre

Dr. John Cush RheumNow

1 year ago
Factors Associated with Poor Vaccine Response in Rituximab: Dr. Yuzaiful Yusof (@Yuz6Yusof) discusses abstract #0437 presented at the #ACR21 annual meeting.https://t.co/T0PFiZlbTa https://t.co/idj5T7j7ke
Update on Safety, Effectiveness of SARS-CoV-2 vaccines in SLE from Dr. Yuz Yusof ( @Yuz6Yusof)
It's almost a year since

Dr. John Cush RheumNow

1 year ago
Update on Safety, Effectiveness of SARS-CoV-2 vaccines in SLE from Dr. Yuz Yusof ( @Yuz6Yusof) It's almost a year since the Pfizer-BioNTech SARS-CoV-2 vaccine has been made available by the FDA under EUA. But is the vaccine safe for people with lupus?https://t.co/i3HeCvS6El https://t.co/Tn0nWKrK4T
EULAR19.abstract.jpg (keep)
Hitting the home stretch, day 3 presentations were big! Here are a few of my favorites: Secukinumab Efficacy in Enthesitis-Related and Juvenile Psoriatic Arthritis. Abstract 1424 – Dr. Hermine…
RT @RichardPAConway: GRA @rheum_covid data presented by @mugartegil. African-American and Hispanic individuals with SLE

Richard Conway RichardPAConway

1 year ago
GRA @rheum_covid data presented by @mugartegil. African-American and Hispanic individuals with SLE have MUCH worse COVID-19 outcomes. Likely related socioeconomic and health disparities. Abstr#1933 #ACR21 @RheumNow https://t.co/YUoOeIxN7O
×